The University of Toledo

The use of stem cells and natural peptide (amino acids) to prevent heart disease and obesity and to treat kidney disease and bone loss are some of the interesting research projects by faculty in The University of Toledo College of Medicine.

Dr. Nader Abraham, professor and chair of the UT Department of Physiology and Pharmacology, will explain his stem cell research when he and other faculty members participate in Research Day Saturday, March 27.

“When we can get together and interact with each other, we exchange information and techniques and get new ideas, leading to better translational research for treatment of human diseases,” Abraham said. “This type of event also encourages medical and graduate students to get involved in research because if they don’t get involved in the translational research and incorporate physiology and basic science knowledge, we will lag behind in future research and the development of innovative therapeutic strategies.”

The College of Medicine Research Day will take place from 8 a.m. to 4 p.m. Saturday, March 27, in the Dana Conference Center. More than 100 faculty members have registered to share their research through oral and poster presentations.

“This could be really the first opportunity for some to meet with their colleagues in different departments and learn about their research and exchange scientific ideas,” said Dr. Akira Takashima, professor and chair of the Department of Medical Microbiology and Immunology. “I’m expecting such interactions will ignite various collaborative projects.”

The morning will include lectures that describe research in the areas of cancer biology, infection, immunity and transplantation, orthopedic and biomedical engineering, cardiovascular and metabolic diseases, and neurosciences.

Research Day will continue in the afternoon with poster presentations followed by time for networking and socializing.

This entry was posted  on  Wednesday, March 24th, 2010 at  5:31 am and is filed under  Events, UToday.
You can follow any responses to this entry through the RSS 2.0 feed.  You can leave a response, or trackback from your own site.